Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Obstructive Lung Diseases

  Free Subscription

Articles published in Respir Res

Retrieve available abstracts of 366 articles:
HTML format

Single Articles

    July 2021
  1. TAKEDA K, Kim SH, Joetham A, Petrache I, et al
    Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema.
    Respir Res. 2021;22:207.
    PubMed     Abstract available

  2. WARREN KJ, Poole JA, Sweeter JM, DeVasure JM, et al
    Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation.
    Respir Res. 2021;22:206.
    PubMed     Abstract available

  3. O'BEIRNE SL, Salit J, Kaner RJ, Crystal RG, et al
    Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.
    Respir Res. 2021;22:200.
    PubMed     Abstract available

    June 2021
  4. PAPAKONSTANTINOU E, Koletsa T, Zhou L, Fang L, et al
    Bronchial thermoplasty in asthma: an exploratory histopathological evaluation in distinct asthma endotypes/phenotypes.
    Respir Res. 2021;22:186.
    PubMed     Abstract available

  5. LEMIERE C, Taille C, Lee JK, Smith SG, et al
    Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials.
    Respir Res. 2021;22:184.
    PubMed     Abstract available

  6. MO Y, Ye L, Cai H, Zhu G, et al
    SERPINB10 contributes to asthma by inhibiting the apoptosis of allergenic Th2 cells.
    Respir Res. 2021;22:178.
    PubMed     Abstract available

  7. WARDZYNSKA A, Pawelczyk M, Rywaniak J, Makowska J, et al
    Circulating miRNA expression in asthmatics is age-related and associated with clinical asthma parameters, respiratory function and systemic inflammation.
    Respir Res. 2021;22:177.
    PubMed     Abstract available

  8. GIBSON PG, Prazma CM, Chupp GL, Bradford ES, et al
    Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions.
    Respir Res. 2021;22:171.
    PubMed     Abstract available

  9. ABDO M, Uddin M, Goldmann T, Marwitz S, et al
    Raised sputum extracellular DNA confers lung function impairment and poor symptom control in an exacerbation-susceptible phenotype of neutrophilic asthma.
    Respir Res. 2021;22:167.
    PubMed     Abstract available

  10. KUROKAWA A, Kondo M, Arimura K, Ashino S, et al
    Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese mice.
    Respir Res. 2021;22:166.
    PubMed     Abstract available

    May 2021
  11. WATSON A, Oberg L, Angermann B, Spalluto CM, et al
    Dysregulation of COVID-19 related gene expression in the COPD lung.
    Respir Res. 2021;22:164.
    PubMed     Abstract available

  12. PADILLA-GALO A, Garcia-Ruiz AJ, Levy Abitbol RC, Olveira C, et al
    Real-life cost-effectiveness of benralizumab in patients with severe asthma.
    Respir Res. 2021;22:163.
    PubMed     Abstract available

  13. LAMB D, De Sousa D, Quast K, Fundel-Clemens K, et al
    RORgammat inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma.
    Respir Res. 2021;22:158.
    PubMed     Abstract available

  14. PERTZOV B, Ronen M, Rosengarten D, Shitenberg D, et al
    Use of capnography for prediction of obstruction severity in non-intubated COPD and asthma patients.
    Respir Res. 2021;22:154.
    PubMed     Abstract available

  15. MORICHIKA D, Taniguchi A, Oda N, Fujii U, et al
    Loss of IL-33 enhances elastase-induced and cigarette smoke extract-induced emphysema in mice.
    Respir Res. 2021;22:150.
    PubMed     Abstract available

  16. LIU MC, Chipps B, Munoz X, Devouassoux G, et al
    Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics.
    Respir Res. 2021;22:144.
    PubMed     Abstract available

  17. WANG T, Zhou Y, Kong N, Zhang J, et al
    Weight gain from early to middle adulthood increases the risk of incident asthma later in life in the United States: a retrospective cohort study.
    Respir Res. 2021;22:139.
    PubMed     Abstract available

  18. RAHERISON-SEMJEN C, Parrat E, Nocent-Eijnani C, Mangiapan G, et al
    FASE-CPHG Study: identification of asthma phenotypes in the French Severe Asthma Study using cluster analysis.
    Respir Res. 2021;22:136.
    PubMed     Abstract available

    April 2021
  19. KWOK WC, Ho JCM, Tam TCC, Ip MSM, et al
    Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications.
    Respir Res. 2021;22:132.
    PubMed     Abstract available

  20. CHEN A, Diaz-Soto MP, Sanmamed MF, Adams T, et al
    Single-cell characterization of a model of poly I:C-stimulated peripheral blood mononuclear cells in severe asthma.
    Respir Res. 2021;22:122.
    PubMed     Abstract available

  21. WORTH H, Criee CP, Vogelmeier CF, Kardos P, et al
    Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany.
    Respir Res. 2021;22:108.
    PubMed     Abstract available

  22. SADATSAFAVI M, Khakban A, Tavakoli H, Ehteshami-Afshar S, et al
    Trends in oral corticosteroids use in severe asthma: a 14-year population-based study.
    Respir Res. 2021;22:103.
    PubMed     Abstract available

    March 2021
  23. VAN ZELST CM, Kasteleyn MJ, van Noort EMJ, Rutten-van Molken MPMH, et al
    The impact of the involvement of a healthcare professional on the usage of an eHealth platform: a retrospective observational COPD study.
    Respir Res. 2021;22:88.
    PubMed     Abstract available

  24. SHAHANGIAN K, Ngan DA, Chen HHR, Oh Y, et al
    IL-4Ralpha blockade reduces influenza-associated morbidity in a murine model of allergic asthma.
    Respir Res. 2021;22:75.
    PubMed     Abstract available

    February 2021
  25. WU TD, Fawzy A, Kinney GL, Bon J, et al
    Metformin use and respiratory outcomes in asthma-COPD overlap.
    Respir Res. 2021;22:70.
    PubMed     Abstract available

  26. CALMES D, Huynen P, Paulus V, Henket M, et al
    Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype.
    Respir Res. 2021;22:72.
    PubMed     Abstract available

  27. BEKAERT S, Rocks N, Vanwinge C, Noel A, et al
    Asthma-related inflammation promotes lung metastasis of breast cancer cells through CCL11-CCR3 pathway.
    Respir Res. 2021;22:61.
    PubMed     Abstract available

  28. EHTESHAMI-AFSHAR S, Crothers K, Rodwin B, Bade B, et al
    Does pulmonary subspecialty referral from primary care affect the adherence to vaccination recommendations in COPD patients?
    Respir Res. 2021;22:50.
    PubMed     Abstract available

  29. KERMANI NZ, Song WJ, Badi Y, Versi A, et al
    Correction to: Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma.
    Respir Res. 2021;22:47.

  30. HU Y, Chen Y, Liu S, Jiang F, et al
    Breastfeeding duration modified the effects of neonatal and familial risk factors on childhood asthma and allergy: a population-based study.
    Respir Res. 2021;22:41.
    PubMed     Abstract available

  31. TAKEUCHI H, Hasan SMT, Zaman K, Takanashi S, et al
    Impact of Haemophilus influenzae type b combination vaccination on asthma symptoms and pneumonia in 5-year-old children in rural Bangladesh: a longitudinal study and comparison with a previous cross-sectional study.
    Respir Res. 2021;22:35.
    PubMed     Abstract available

    January 2021
  32. FENG Z, Wang J, Xie Y, Li J, et al
    Effects of exercise-based pulmonary rehabilitation on adults with asthma: a systematic review and meta-analysis.
    Respir Res. 2021;22:33.
    PubMed     Abstract available

  33. MAGNUSSEN H, Lucas S, Lapperre T, Quint JK, et al
    Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study.
    Respir Res. 2021;22:25.
    PubMed     Abstract available

  34. LAM R, Kwon S, Riggs J, Sunseri M, et al
    Dietary phenotype and advanced glycation end-products predict WTC-obstructive airways disease: a longitudinal observational study.
    Respir Res. 2021;22:19.
    PubMed     Abstract available

  35. SHIRAHATA T, Sato H, Yogi S, Inoue K, et al
    The product of trunk muscle area and density on the CT image is a good indicator of energy expenditure in patients with or at risk for COPD.
    Respir Res. 2021;22:18.
    PubMed     Abstract available

  36. SCHLEICH F, Graff S, Guissard F, Henket M, et al
    Asthma in elderly is characterized by increased sputum neutrophils, lower airway caliber variability and air trapping.
    Respir Res. 2021;22:15.
    PubMed     Abstract available

  37. KERMANI NZ, Song WJ, Badi Y, Versi A, et al
    Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma.
    Respir Res. 2021;22:10.
    PubMed     Abstract available

    November 2020
  38. ALNAJEM A, Redha A, Alroumi D, Alshammasi A, et al
    Use of electronic cigarettes and secondhand exposure to their aerosols are associated with asthma symptoms among adolescents: a cross-sectional study.
    Respir Res. 2020;21:300.
    PubMed     Abstract available

    October 2020
  39. SINGH D, Virchow JC, Canonica GW, Vele A, et al
    Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER.
    Respir Res. 2020;21:285.
    PubMed     Abstract available

  40. ABDO M, Watz H, Veith V, Kirsten AM, et al
    Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study.
    Respir Res. 2020;21:278.
    PubMed     Abstract available

  41. MENZIES-GOW A, Ponnarambil S, Downie J, Bowen K, et al
    DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
    Respir Res. 2020;21:279.
    PubMed     Abstract available

  42. NEMOTO M, Nei Y, Bartholmai B, Yoshida K, et al
    Automated computed tomography quantification of fibrosis predicts prognosis in combined pulmonary fibrosis and emphysema in a real-world setting: a single-centre, retrospective study.
    Respir Res. 2020;21:275.
    PubMed     Abstract available

  43. GROTH EE, Weber M, Bahmer T, Pedersen F, et al
    Exploration of the sputum methylome and omics deconvolution by quadratic programming in molecular profiling of asthma and COPD: the road to sputum omics 2.0.
    Respir Res. 2020;21:274.
    PubMed     Abstract available

  44. MENZIES-GOW A, Wechsler ME, Brightling CE
    Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
    Respir Res. 2020;21:268.
    PubMed     Abstract available

  45. MENZIES-GOW A, Colice G, Griffiths JM, Almqvist G, et al
    NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
    Respir Res. 2020;21:266.
    PubMed     Abstract available

  46. WECHSLER ME, Colice G, Griffiths JM, Almqvist G, et al
    SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
    Respir Res. 2020;21:264.
    PubMed     Abstract available

  47. EMSON C, Diver S, Chachi L, Megally A, et al
    CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma.
    Respir Res. 2020;21:265.
    PubMed     Abstract available

    September 2020
  48. MATUSIAK M, Schurch CM
    Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics.
    Respir Res. 2020;21:252.
    PubMed     Abstract available

  49. MILLER D, Vaidya S, Jauernig J, Ethell B, et al
    Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patients.
    Respir Res. 2020;21:248.
    PubMed     Abstract available

  50. GAO P, Tang K, Lu Y, Huang Z, et al
    Pentraxin 3 promotes airway inflammation in experimental asthma.
    Respir Res. 2020;21:237.
    PubMed     Abstract available

  51. JIMENEZ E, Astbury C, Albayaty M, Wahlby-Hamren U, et al
    Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacolog
    Respir Res. 2020;21.
    PubMed     Abstract available

  52. ZENG H, Li T, He X, Cai S, et al
    Oxidative stress mediates the apoptosis and epigenetic modification of the Bcl-2 promoter via DNMT1 in a cigarette smoke-induced emphysema model.
    Respir Res. 2020;21:229.
    PubMed     Abstract available

    August 2020
  53. SUGAWARA H, Saito A, Yokoyama S, Tsunematsu K, et al
    A retrospective analysis of usefulness of impulse oscillometry system in the treatment of asthma.
    Respir Res. 2020;21:226.
    PubMed     Abstract available

  54. GRAFF S, Vanwynsberghe S, Brusselle G, Hanon S, et al
    Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry.
    Respir Res. 2020;21:214.
    PubMed     Abstract available

    July 2020
  55. TOMMOLA M, Won HK, Ilmarinen P, Jung H, et al
    Relationship between age and bronchodilator response at diagnosis in adult-onset asthma.
    Respir Res. 2020;21:179.
    PubMed     Abstract available

  56. VELLA G, Lunding L, Ritzmann F, Honecker A, et al
    The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma.
    Respir Res. 2020;21:176.
    PubMed     Abstract available

  57. ZHANG J, Zhu Z, Zuo X, Pan H, et al
    The role of NTHi colonization and infection in the pathogenesis of neutrophilic asthma.
    Respir Res. 2020;21:170.
    PubMed     Abstract available

  58. ABDULNASSER HARFOUSH S, Hannig M, Le DD, Heck S, et al
    High-dose intranasal application of titanium dioxide nanoparticles induces the systemic uptakes and allergic airway inflammation in asthmatic mice.
    Respir Res. 2020;21:168.
    PubMed     Abstract available

    June 2020
  59. ZANTAH M, Dotan Y, Dass C, Zhao H, et al
    Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
    Respir Res. 2020;21:164.
    PubMed     Abstract available

  60. KERWIN E, Pascoe S, Bailes Z, Nathan R, et al
    A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids.
    Respir Res. 2020;21:148.
    PubMed     Abstract available

  61. ESTEBAN C, Arostegui I, Aramburu A, Moraza J, et al
    Predictive factors over time of health-related quality of life in COPD patients.
    Respir Res. 2020;21:138.
    PubMed     Abstract available

  62. DAY NC, Kumar S, Criner G, Dransfield M, et al
    Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial.
    Respir Res. 2020;21:139.
    PubMed     Abstract available

  63. MATHYSSEN C, Aelbrecht C, Serre J, Everaerts S, et al
    Local expression profiles of vitamin D-related genes in airways of COPD patients.
    Respir Res. 2020;21:137.
    PubMed     Abstract available

  64. SINGH D, Criner GJ, Naya I, Jones PW, et al
    Measuring disease activity in COPD: is clinically important deterioration the answer?
    Respir Res. 2020;21:134.
    PubMed     Abstract available

    May 2020
  65. KIM T, Cho HB, Kim WJ, Lee CH, et al
    Quantitative CT-based structural alterations of segmental airways in cement dust-exposed subjects.
    Respir Res. 2020;21:133.
    PubMed     Abstract available

  66. FERGUSON GT, Brown N, Compton C, Corbridge TC, et al
    Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials.
    Respir Res. 2020;21:131.
    PubMed     Abstract available

  67. MARTINEZ FJ, Lipworth BJ, Rabe KF, Collier DJ, et al
    Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies.
    Respir Res. 2020;21:128.
    PubMed     Abstract available

  68. GHOSH N, Choudhury P, Kaushik SR, Arya R, et al
    Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).
    Respir Res. 2020;21:126.
    PubMed     Abstract available

  69. RAYMAKERS A, Sin DD, Sadatsafavi M, FitzGerald JM, et al
    Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study.
    Respir Res. 2020;21:118.
    PubMed     Abstract available

  70. XU W, Wang Y, Ma Y, Yang J, et al
    MiR-223 plays a protecting role in neutrophilic asthmatic mice through the inhibition of NLRP3 inflammasome.
    Respir Res. 2020;21:116.
    PubMed     Abstract available

  71. SIEVI NA, Kohler M, Clarenbach CF
    Respond to the letter to the editor by Van't Hul et al. regarding the published manuscript "can do, don't do" are not the lazy ones: a longitudinal study on physical functioning in patients with COPD" by Sievi et al.(1).
    Respir Res. 2020;21:114.

  72. VAN 'T HUL AJA, Koolen EHN, van Hees HWJ, van den Borst BB, et al
    The 'can do, do do' concept in COPD; quadrant interpretation, affiliation and tracking longitudinal changes.
    Respir Res. 2020;21:112.

  73. WEIDNER J, Ekerljung L, Malmhall C, Miron N, et al
    Circulating microRNAs correlate to clinical parameters in individuals with allergic and non-allergic asthma.
    Respir Res. 2020;21:107.
    PubMed     Abstract available

  74. GREULICH T, Tuffers J, Mager S, Eder A, et al
    High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis.
    Respir Res. 2020;21:106.
    PubMed     Abstract available

  75. OCCHIPINTI M, Paoletti M, Crapo JD, Make BJ, et al
    Validation of a method to assess emphysema severity by spirometry in the COPDGene study.
    Respir Res. 2020;21:103.
    PubMed     Abstract available

  76. WILSON AC, Kumar PL, Lee S, Parker MM, et al
    Heme metabolism genes Downregulated in COPD Cachexia.
    Respir Res. 2020;21:100.
    PubMed     Abstract available

    April 2020
  77. MACKAY AJ, Kostikas K, Roche N, Frent SM, et al
    Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study.
    Respir Res. 2020;21:93.
    PubMed     Abstract available

  78. SCHERR A, Schumann DM, Karakioulaki M, Franchetti L, et al
    Endothelial dysfunction is not a predictor of outcome in chronic obstructive pulmonary disease.
    Respir Res. 2020;21:90.
    PubMed     Abstract available

  79. LI W, Gao R, Xin T, Gao P, et al
    Different expression levels of interleukin-35 in asthma phenotypes.
    Respir Res. 2020;21:89.
    PubMed     Abstract available

  80. WATZ H, Hohlfeld JM, Singh D, Beier J, et al
    Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study.
    Respir Res. 2020;21:87.
    PubMed     Abstract available

  81. DING Y, Yang Y, Li Q, Feng Q, et al
    The correlation between CYP4F2 variants and chronic obstructive pulmonary disease risk in Hainan Han population.
    Respir Res. 2020;21:86.
    PubMed     Abstract available

  82. TUNG LF, Shen SY, Shih HH, Chen YT, et al
    Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study.
    Respir Res. 2020;21:84.
    PubMed     Abstract available

    March 2020
  83. BOUQUET J, Tabor DE, Silver JS, Nair V, et al
    Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort.
    Respir Res. 2020;21:77.
    PubMed     Abstract available

  84. LANGTON D, Bennetts K, Noble P, Plummer V, et al
    Bronchial thermoplasty reduces airway resistance.
    Respir Res. 2020;21:76.
    PubMed     Abstract available

  85. GOVONI M, Bassi M, Vezzoli S, Lucci G, et al
    Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.
    Respir Res. 2020;21:72.
    PubMed     Abstract available

  86. ZHENG J, Xu JF, Jenkins M, Assam PN, et al
    Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naive patients with chronic obstructive pulmonary disease: a post-hoc analysis of the randomized PINNACLE trials.
    Respir Res. 2020;21:69.
    PubMed     Abstract available

  87. GAO S, Chen J, Xie J, Wang J, et al
    The effects of BAFF on T lymphocytes in chronic obstructive pulmonary disease.
    Respir Res. 2020;21:66.
    PubMed     Abstract available

  88. MAGDY DM, Metwally A
    Effect of average volume-assured pressure support treatment on health-related quality of life in COPD patients with chronic hypercapnic respiratory failure: a randomized trial.
    Respir Res. 2020;21:64.
    PubMed     Abstract available

  89. PASCUAL-GUARDIA S, Ataya M, Ramirez-Martinez I, Yelamos J, et al
    Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients.
    Respir Res. 2020;21:63.
    PubMed     Abstract available

    February 2020
  90. MAO S, Wu L, Shi W
    Prevalence and distribution patterns of allergens among children with asthma and asthma-like symptoms in Shanghai, China.
    Respir Res. 2020;21:57.
    PubMed     Abstract available

  91. AXSON EL, Ragutheeswaran K, Sundaram V, Bloom CI, et al
    Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis.
    Respir Res. 2020;21:54.
    PubMed     Abstract available

  92. GOORSENBERG AWM, d'Hooghe JNS, Slats AM, van den Aardweg JG, et al
    Resistance of the respiratory system measured with forced oscillation technique (FOT) correlates with bronchial thermoplasty response.
    Respir Res. 2020;21:52.
    PubMed     Abstract available

  93. SALVI SS, Brashier BB, Londhe J, Pyasi K, et al
    Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease.
    Respir Res. 2020;21:50.
    PubMed     Abstract available

  94. XIE M, Liu X, Cao X, Guo M, et al
    Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017.
    Respir Res. 2020;21:49.
    PubMed     Abstract available

  95. SINGH D, Martinez FJ, Watz H, Bengtsson T, et al
    A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD.
    Respir Res. 2020;21:47.
    PubMed     Abstract available

  96. TAM A, Tanabe N, Churg A, Wright JL, et al
    Sex differences in lymphoid follicles in COPD airways.
    Respir Res. 2020;21:46.
    PubMed     Abstract available

  97. PINDUS M, Orru H, Jogi R
    Change in the symptom profile treated as asthma - two cross-sectional studies twenty years apart.
    Respir Res. 2020;21:41.
    PubMed     Abstract available

  98. PADBERG I, Schneider A, Rohmann JL, Kelley SW, et al
    Impact of COPD and anemia on motor and cognitive performance in the general older population: results from the English longitudinal study of ageing.
    Respir Res. 2020;21:40.
    PubMed     Abstract available

    January 2020
  99. FRATTA PASINI AM, Stranieri C, Ferrari M, Garbin U, et al
    Oxidative stress and Nrf2 expression in peripheral blood mononuclear cells derived from COPD patients: an observational longitudinal study.
    Respir Res. 2020;21:37.
    PubMed     Abstract available

  100. MOUI A, Klein M, Hassoun D, Dijoux E, et al
    The IL-15 / sIL-15Ralpha complex modulates immunity without effect on asthma features in mouse.
    Respir Res. 2020;21:33.
    PubMed     Abstract available

  101. MCGEACHIE MJ, Sordillo JE, Dahlin A, Wang AL, et al
    Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy.
    Respir Res. 2020;21:31.
    PubMed     Abstract available

  102. TANNO A, Fujino N, Yamada M, Sugiura H, et al
    Decreased expression of a phagocytic receptor Siglec-1 on alveolar macrophages in chronic obstructive pulmonary disease.
    Respir Res. 2020;21:30.
    PubMed     Abstract available

  103. SIEVI NA, Brack T, Brutsche MH, Frey M, et al
    "Can do, don't do" are not the lazy ones: a longitudinal study on physical functioning in patients with COPD.
    Respir Res. 2020;21:27.
    PubMed     Abstract available

  104. DIVO MJ, DePietro MR, Horton JR, Maguire CA, et al
    Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial.
    Respir Res. 2020;21:26.
    PubMed     Abstract available

  105. KAHNERT K, Fohrenbach M, Lucke T, Alter P, et al
    The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET.
    Respir Res. 2020;21:28.
    PubMed     Abstract available

  106. VOGELBERG C, Goldstein S, Graham L, Kaplan A, et al
    A comparison of tiotropium, long-acting beta2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma.
    Respir Res. 2020;21:19.
    PubMed     Abstract available

  107. ARTARAZ A, Crichton ML, Finch S, Abo-Leyah H, et al
    Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST).
    Respir Res. 2020;21:18.
    PubMed     Abstract available

  108. JIANG JX, Shen HJ, Guan Y, Jia YL, et al
    ZDHXB-101 (3',5-Diallyl-2, 4'-dihydroxy-[1,1'-biphen-yl]-3,5'-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator
    Respir Res. 2020;21:22.
    PubMed     Abstract available

  109. PEREA L, Rodrigo-Troyano A, Canto E, Dominguez-Alvarez M, et al
    Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity.
    Respir Res. 2020;21:21.
    PubMed     Abstract available

  110. LIAO Y, Li P, Wang Y, Chen H, et al
    Construction of asthma related competing endogenous RNA network revealed novel long non-coding RNAs and potential new drugs.
    Respir Res. 2020;21:14.
    PubMed     Abstract available

  111. LONG GH, Southworth T, Kolsum U, Donaldson GC, et al
    The stability of blood Eosinophils in chronic obstructive pulmonary disease.
    Respir Res. 2020;21:15.
    PubMed     Abstract available

  112. BAFADHEL M, Singh D, Jenkins C, Peterson S, et al
    Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis.
    Respir Res. 2020;21:17.
    PubMed     Abstract available

  113. WALSCHER J, Gross B, Morisset J, Johannson KA, et al
    Comorbidities and survival in patients with chronic hypersensitivity pneumonitis.
    Respir Res. 2020;21:12.
    PubMed     Abstract available

  114. DENHOLM R, van der Werf ET, Hay AD
    Use of antibiotics and asthma medication for acute lower respiratory tract infections in people with and without asthma: retrospective cohort study.
    Respir Res. 2020;21:4.
    PubMed     Abstract available

  115. HARTLEY BF, Barnes NC, Lettis S, Compton CH, et al
    Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis.
    Respir Res. 2020;21:5.
    PubMed     Abstract available

  116. HARRIES TH, Rowland V, Corrigan CJ, Marshall IJ, et al
    Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis.
    Respir Res. 2020;21:3.
    PubMed     Abstract available

    December 2019
  117. IBRAHIM H, O'Sullivan R, Casey D, Murphy J, et al
    The effectiveness of Reslizumab in severe asthma treatment: a real-world experience.
    Respir Res. 2019;20:289.
    PubMed     Abstract available

  118. LEAKER BR, Singh D, Lindgren S, Almqvist G, et al
    Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study.
    Respir Res. 2019;20:288.
    PubMed     Abstract available

  119. CHEN YF, Huang G, Wang YM, Cheng M, et al
    Exchange protein directly activated by cAMP (Epac) protects against airway inflammation and airway remodeling in asthmatic mice.
    Respir Res. 2019;20:285.
    PubMed     Abstract available

  120. KIM SH, Pei QM, Jiang P, Liu J, et al
    Upregulation of MUC5AC by VEGF in human primary bronchial epithelial cells: implications for asthma.
    Respir Res. 2019;20:282.
    PubMed     Abstract available

  121. GOUSSAULT H, Salvator H, Catherinot E, Chabi ML, et al
    Primary immunodeficiency-related bronchiectasis in adults: comparison with bronchiectasis of other etiologies in a French reference center.
    Respir Res. 2019;20:275.
    PubMed     Abstract available

  122. SIN S, Yun SY, Kim JM, Park CM, et al
    Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis.
    Respir Res. 2019;20:271.
    PubMed     Abstract available

    November 2019
  123. VANDERS RL, Hsu A, Gibson PG, Murphy VE, et al
    Nasal epithelial cells to assess in vitro immune responses to respiratory virus infection in pregnant women with asthma.
    Respir Res. 2019;20:259.
    PubMed     Abstract available

  124. HAKANSSON KEJ, Rasmussen LJH, Godtfredsen NS, Tupper OD, et al
    The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma - a retrospective cohort study.
    Respir Res. 2019;20:258.
    PubMed     Abstract available

    October 2019
  125. HADDAD A, Gaudet M, Plesa M, Allakhverdi Z, et al
    Neutrophils from severe asthmatic patients induce epithelial to mesenchymal transition in healthy bronchial epithelial cells.
    Respir Res. 2019;20:234.
    PubMed     Abstract available

  126. HOSSEINI M, Almasi-Hashiani A, Sepidarkish M, Maroufizadeh S, et al
    Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis.
    Respir Res. 2019;20:229.
    PubMed     Abstract available

  127. BAK SH, Kwon SO, Han SS, Kim WJ, et al
    Computed tomography-derived area and density of pectoralis muscle associated disease severity and longitudinal changes in chronic obstructive pulmonary disease: a case control study.
    Respir Res. 2019;20:226.
    PubMed     Abstract available

  128. NADER CP, Cidem A, Verrills NM, Ammit AJ, et al
    Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer.
    Respir Res. 2019;20:222.
    PubMed     Abstract available

  129. PINTO-PLATA V, Casanova C, Divo M, Tesfaigzi Y, et al
    Plasma metabolomics and clinical predictors of survival differences in COPD patients.
    Respir Res. 2019;20:219.
    PubMed     Abstract available

  130. KIRSCH F, Schramm A, Schwarzkopf L, Lutter JI, et al
    Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study.
    Respir Res. 2019;20:215.
    PubMed     Abstract available

  131. LIU J, Dong YQ, Yin J, Yao J, et al
    Meta-analysis of vitamin D and lung function in patients with asthma.
    Respir Res. 2019;20:161.
    PubMed     Abstract available

    September 2019
  132. BONNARDEL E, Prevel R, Campagnac M, Dubreuil M, et al
    Determination of reliable lung function parameters in intubated mice.
    Respir Res. 2019;20:211.
    PubMed     Abstract available

  133. KO FW, Chan PK, Chan RWY, Chan KP, et al
    Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease.
    Respir Res. 2019;20:210.
    PubMed     Abstract available

  134. AKIKI Z, Andrianjafimasy M, Zerimech F, Le Moual N, et al
    High level of fluorescent oxidation products and worsening of asthma control over time.
    Respir Res. 2019;20:203.
    PubMed     Abstract available

  135. LIANG X, He X, Li Y, Wang J, et al
    Lyn regulates epithelial-mesenchymal transition in CS-exposed model through Smad2/3 signaling.
    Respir Res. 2019;20:201.
    PubMed     Abstract available

  136. WELLMERLING JH, Chang SW, Kim E, Osman WH, et al
    Reduced expression of the Ion channel CFTR contributes to airspace enlargement as a consequence of aging and in response to cigarette smoke in mice.
    Respir Res. 2019;20:200.
    PubMed     Abstract available

    August 2019
  137. MOURONTE-ROIBAS C, Leiro-Fernandez V, Ruano-Ravina A, Ramos-Hernandez C, et al
    Predictive value of a series of inflammatory markers in COPD for lung cancer diagnosis: a case-control study.
    Respir Res. 2019;20:198.
    PubMed     Abstract available

  138. PASCOE SJ, Papi A, Midwinter D, Lettis S, et al
    Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:195.
    PubMed     Abstract available

  139. ZYSMAN M, Burgel PR, Court-Fortune I, Brinchault-Rabin G, et al
    Relationship between gender and survival in a real-life cohort of patients with COPD.
    Respir Res. 2019;20:191.
    PubMed     Abstract available

  140. SIDHAYE VK, Holbrook JT, Burke A, Sudini KR, et al
    Compartmentalization of anti-oxidant and anti-inflammatory gene expression in current and former smokers with COPD.
    Respir Res. 2019;20:190.
    PubMed     Abstract available

  141. ROCHE N, Antoniadis A, Hess D, Li PZ, et al
    Are there specific clinical characteristics associated with physician's treatment choices in COPD?
    Respir Res. 2019;20:189.
    PubMed     Abstract available

  142. ANDREAS S, Rover C, Heinz J, Straube S, et al
    Decline of COPD exacerbations in clinical trials over two decades - a systematic review and meta-regression.
    Respir Res. 2019;20:186.
    PubMed     Abstract available

  143. MUNESWARAO J, Hassali MA, Ibrahim B, Saini B, et al
    It is time to change the way we manage mild asthma: an update in GINA 2019.
    Respir Res. 2019;20:183.
    PubMed     Abstract available

  144. SINGH D, Beeh KM, Colgan B, Kornmann O, et al
    Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.
    Respir Res. 2019;20:180.
    PubMed     Abstract available

  145. EDRIS A, De Feyter S, Maes T, Joos G, et al
    Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis.
    Respir Res. 2019;20:179.
    PubMed     Abstract available

  146. VOGELMEIER CF, Kostikas K, Fang J, Tian H, et al
    Evaluation of exacerbations and blood eosinophils in UK and US COPD populations.
    Respir Res. 2019;20:178.
    PubMed     Abstract available

  147. LEE KM, Lee G, Kim A, Mok J, et al
    Clinical outcomes of radial probe endobronchial ultrasound using a guide sheath for diagnosis of peripheral lung lesions in patients with pulmonary emphysema.
    Respir Res. 2019;20:177.
    PubMed     Abstract available

  148. TAKIGUCHI H, Chen V, Obeidat M, Hollander Z, et al
    Effect of short-term oral prednisone therapy on blood gene expression: a randomised controlled clinical trial.
    Respir Res. 2019;20:176.
    PubMed     Abstract available

  149. LEATHER DA, Yates L, Svedsater H, Jacques L, et al
    Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?
    Respir Res. 2019;20:173.
    PubMed     Abstract available

    July 2019
  150. ALBERS FC, Papi A, Taille C, Bratton DJ, et al
    Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA.
    Respir Res. 2019;20:169.
    PubMed     Abstract available

  151. AGARWAL AR, Kadam S, Brahme A, Agrawal M, et al
    Systemic Immuno-metabolic alterations in chronic obstructive pulmonary disease (COPD).
    Respir Res. 2019;20:171.
    PubMed     Abstract available

  152. THULBORN SJ, Mistry V, Brightling CE, Moffitt KL, et al
    Neutrophil elastase as a biomarker for bacterial infection in COPD.
    Respir Res. 2019;20:170.
    PubMed     Abstract available

  153. KERWIN EM, Ferguson GT, Mo M, DeAngelis K, et al
    Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study.
    Respir Res. 2019;20:167.
    PubMed     Abstract available

  154. YANG J, Ramirez Moral I, van 't Veer C, de Vos AF, et al
    Complement factor C5 inhibition reduces type 2 responses without affecting group 2 innate lymphoid cells in a house dust mite induced murine asthma model.
    Respir Res. 2019;20:165.
    PubMed     Abstract available

  155. ALDABAYAN YS, Ridsdale HA, Alrajeh AM, Aldhahir AM, et al
    Pulmonary rehabilitation, physical activity and aortic stiffness in COPD.
    Respir Res. 2019;20:166.
    PubMed     Abstract available

  156. KIM W, Cho MH, Sakornsakolpat P, Lynch DA, et al
    DSP variants may be associated with longitudinal change in quantitative emphysema.
    Respir Res. 2019;20:160.
    PubMed     Abstract available

  157. LIU G, Betts C, Cunoosamy DM, Aberg PM, et al
    Use of precision cut lung slices as a translational model for the study of lung biology.
    Respir Res. 2019;20:162.
    PubMed     Abstract available

  158. HALPIN DMG, Meltzer EO, Pisternick-Ruf W, Moroni-Zentgraf P, et al
    Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1.
    Respir Res. 2019;20:159.
    PubMed     Abstract available

  159. LANGTON D, Sloan G, Banks C, Bennetts K, et al
    Bronchial thermoplasty increases airway volume measured by functional respiratory imaging.
    Respir Res. 2019;20:157.
    PubMed     Abstract available

  160. CSOMA B, Bikov A, Nagy L, Toth B, et al
    Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD.
    Respir Res. 2019;20:156.
    PubMed     Abstract available

  161. HAGHIGHI B, Choi S, Choi J, Hoffman EA, et al
    Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS).
    Respir Res. 2019;20:153.
    PubMed     Abstract available

  162. TRUDZINSKI FC, Alqudrah M, Omlor A, Zewinger S, et al
    Consequences of chronic kidney disease in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:151.
    PubMed     Abstract available

  163. CRUZ T, Lopez-Giraldo A, Noell G, Casas-Recasens S, et al
    Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD).
    Respir Res. 2019;20:152.
    PubMed     Abstract available

  164. PIGNATTI P, Visca D, Cherubino F, Zampogna E, et al
    Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients.
    Respir Res. 2019;20:145.
    PubMed     Abstract available

  165. TALBOOM-KAMP EPWA, Holstege MS, Chavannes NH, Kasteleyn MJ, et al
    Effects of use of an eHealth platform e-Vita for COPD patients on disease specific quality of life domains.
    Respir Res. 2019;20:146.
    PubMed     Abstract available

  166. MA Y, Tong H, Zhang X, Wang M, et al
    Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis.
    Respir Res. 2019;20:144.
    PubMed     Abstract available

  167. SINGH D, D'Urzo AD, Donohue JF, Kerwin EM, et al
    Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective.
    Respir Res. 2019;20:141.
    PubMed     Abstract available

    June 2019
  168. LEAKER BR, Singh D, Nicholson GC, Hezelova B, et al
    Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease.
    Respir Res. 2019;20:132.
    PubMed     Abstract available

  169. O'BRIEN ME, Chandra D, Wilson RC, Karoleski CM, et al
    Loss of skin elasticity is associated with pulmonary emphysema, biomarkers of inflammation, and matrix metalloproteinase activity in smokers.
    Respir Res. 2019;20:128.
    PubMed     Abstract available

  170. VEIL-PICARD M, Soumagne T, Vongthilath R, Annesi-Maesano I, et al
    Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers?
    Respir Res. 2019;20:124.
    PubMed     Abstract available

  171. LIU F, Qu F, Zhang H, Chao L, et al
    The effect and burden modification of heating on adult asthma hospitalizations in Shijiazhuang: a time-series analysis.
    Respir Res. 2019;20:122.
    PubMed     Abstract available

  172. ZHAO J, Li M, Wang Z, Chen J, et al
    Role of PM2.5 in the development and progression of COPD and its mechanisms.
    Respir Res. 2019;20:120.
    PubMed     Abstract available

  173. GERN JE, Jackson DJ, Lemanske RF Jr, Seroogy CM, et al
    The Children's Respiratory and Environmental Workgroup (CREW) birth cohort consortium: design, methods, and study population.
    Respir Res. 2019;20:115.
    PubMed     Abstract available

  174. PRAGMAN AA, Knutson KA, Gould TJ, Isaacson RE, et al
    Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
    Respir Res. 2019;20:114.
    PubMed     Abstract available

  175. WANG Z, Maschera B, Lea S, Kolsum U, et al
    Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:113.
    PubMed     Abstract available

    May 2019
  176. NELSEN LM, Lee LA, Wu W, Lin X, et al
    Reliability, validity and responsiveness of E-RS:COPD in patients with spirometric asthma-COPD overlap.
    Respir Res. 2019;20:107.
    PubMed     Abstract available

  177. XIONG XF, Zhu M, Wu HX, Fan LL, et al
    Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials.
    Respir Res. 2019;20:108.
    PubMed     Abstract available

  178. ROGLIANI P, Matera MG, Page C, Puxeddu E, et al
    Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
    Respir Res. 2019;20:104.
    PubMed     Abstract available

  179. UM-BERGSTROM P, Hallberg J, Pourbazargan M, Berggren-Brostrom E, et al
    Pulmonary outcomes in adults with a history of Bronchopulmonary Dysplasia differ from patients with asthma.
    Respir Res. 2019;20:102.
    PubMed     Abstract available

  180. OCCHIPINTI M, Paoletti M, Bartholmai BJ, Rajagopalan S, et al
    Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD.
    Respir Res. 2019;20:101.
    PubMed     Abstract available

  181. LIU L, Zhang X, Liu Y, Zhang L, et al
    Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations.
    Respir Res. 2019;20:95.
    PubMed     Abstract available

  182. KARMAUS W, Mukherjee N, Janjanam VD, Chen S, et al
    Distinctive lung function trajectories from age 10 to 26 years in men and women and associated early life risk factors - a birth cohort study.
    Respir Res. 2019;20:98.
    PubMed     Abstract available

  183. MCDONALD MN, Wouters EFM, Rutten E, Casaburi R, et al
    It's more than low BMI: prevalence of cachexia and associated mortality in COPD.
    Respir Res. 2019;20:100.
    PubMed     Abstract available

  184. RODRIGUES FM, Demeyer H, Loeckx M, Hornikx M, et al
    Health status deterioration in subjects with mild to moderate airflow obstruction, a six years observational study.
    Respir Res. 2019;20:93.
    PubMed     Abstract available

  185. LI N, He Y, Yang G, Yu Q, et al
    Role of TRPC1 channels in pressure-mediated activation of airway remodeling.
    Respir Res. 2019;20:91.
    PubMed     Abstract available

  186. TRABELSI S, Casas L, Nemery B, Nawrot TS, et al
    Geographies of asthma medication purchase for pre-schoolers in Belgium.
    Respir Res. 2019;20:90.

  187. MIHALTAN F, Adir Y, Antczak A, Porpodis K, et al
    Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study.
    Respir Res. 2019;20:89.
    PubMed     Abstract available

  188. FAWZY A, Anderson JA, Cowans NJ, Crim C, et al
    Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD.
    Respir Res. 2019;20:86.
    PubMed     Abstract available

  189. REN Y, Zhang Y, Fan L, Jiao Q, et al
    The cullin4A is up-regulated in chronic obstructive pulmonary disease patient and contributes to epithelial-mesenchymal transition in small airway epithelium.
    Respir Res. 2019;20:84.
    PubMed     Abstract available

  190. PRAZMA CM, Bel EH, Price RG, Bradford ES, et al
    Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis.
    Respir Res. 2019;20:83.
    PubMed     Abstract available

    April 2019
  191. KANG HR, Hong SH, Ha SY, Kim TB, et al
    Differences in the risk of mood disorders in patients with asthma-COPD overlap and in patients with COPD alone: a nationwide population-based retrospective cohort study in Korea.
    Respir Res. 2019;20:80.
    PubMed     Abstract available

  192. TANABE N, Sato S, Oguma T, Shima H, et al
    Associations of airway tree to lung volume ratio on computed tomography with lung function and symptoms in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:77.
    PubMed     Abstract available

  193. TURA-CEIDE O, Pizarro S, Garcia-Lucio J, Ramirez J, et al
    Progenitor cell mobilisation and recruitment in pulmonary arteries in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:74.
    PubMed     Abstract available

  194. QI Q, Ailiyaer Y, Liu R, Zhang Y, et al
    Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial.
    Respir Res. 2019;20:73.
    PubMed     Abstract available

  195. FAIZ A, van den Berge M, Vermeulen CJ, Ten Hacken NHT, et al
    AGER expression and alternative splicing in bronchial biopsies of smokers and never smokers.
    Respir Res. 2019;20:70.
    PubMed     Abstract available

  196. HO TW, Huang CT, Tsai YJ, Lien AS, et al
    Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:69.
    PubMed     Abstract available

  197. ZHU Z, Wang X, Li X, Lin Y, et al
    Genetic overlap of chronic obstructive pulmonary disease and cardiovascular disease-related traits: a large-scale genome-wide cross-trait analysis.
    Respir Res. 2019;20:64.
    PubMed     Abstract available

  198. MORROW JD, Chase RP, Parker MM, Glass K, et al
    RNA-sequencing across three matched tissues reveals shared and tissue-specific gene expression and pathway signatures of COPD.
    Respir Res. 2019;20:65.
    PubMed     Abstract available

  199. RONNOW SR, Sand JMB, Langholm LL, Manon-Jensen T, et al
    Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
    Respir Res. 2019;20:63.
    PubMed     Abstract available

    March 2019
  200. LEE SH, Lee JH, Yoon HI, Park HY, et al
    Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts.
    Respir Res. 2019;20:62.
    PubMed     Abstract available

  201. ALTER P, Watz H, Kahnert K, Rabe KF, et al
    Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD.
    Respir Res. 2019;20:61.
    PubMed     Abstract available

  202. NAYA I, Tombs L, Lipson DA, Boucot I, et al
    Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis.
    Respir Res. 2019;20:60.
    PubMed     Abstract available

  203. HIGHAM A, Quinn AM, Cancado JED, Singh D, et al
    The pathology of small airways disease in COPD: historical aspects and future directions.
    Respir Res. 2019;20:49.
    PubMed     Abstract available

    February 2019
  204. KHAKBAN A, FitzGerald JM, Tavakoli H, Lynd L, et al
    Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study.
    Respir Res. 2019;20:44.
    PubMed     Abstract available

  205. STOEL BC, Stolk J, Bakker ME, Parr DG, et al
    Regional lung densities in alpha-1 antitrypsin deficiency compared to predicted values.
    Respir Res. 2019;20:45.
    PubMed     Abstract available

  206. SUGAWARA H, Saito A, Yokoyama S, Tsunematsu K, et al
    Comparison of therapeutic effects of inhaled corticosteroids on three subtypes of cough variant asthma as classified by the impulse oscillometry system.
    Respir Res. 2019;20:41.
    PubMed     Abstract available

  207. ZILAEE M, Hosseini SA, Jafarirad S, Abolnezhadian F, et al
    An evaluation of the effects of saffron supplementation on the asthma clinical symptoms and asthma severity in patients with mild and moderate persistent allergic asthma: a double-blind, randomized placebo-controlled trial.
    Respir Res. 2019;20:39.
    PubMed     Abstract available

  208. LI HF, Yan LP, Wang K, Li XT, et al
    Association between ADAM33 polymorphisms and asthma risk: a systematic review and meta-analysis.
    Respir Res. 2019;20:38.
    PubMed     Abstract available

  209. BROWN MN, Fuhr R, Beier J, Su HL, et al
    Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial.
    Respir Res. 2019;20:37.
    PubMed     Abstract available

  210. FLEXEDER C, Zock JP, Jarvis D, Verlato G, et al
    Second-hand smoke exposure in adulthood and lower respiratory health during 20 year follow up in the European Community Respiratory Health Survey.
    Respir Res. 2019;20:33.
    PubMed     Abstract available

  211. CORSICO AG, D'Armini AM, Conio V, Sciortino A, et al
    Persistent exercise limitation after successful pulmonary endoarterectomy: frequency and determinants.
    Respir Res. 2019;20:34.
    PubMed     Abstract available

  212. VON SIEMENS SM, Jorres RA, Behr J, Alter P, et al
    Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study.
    Respir Res. 2019;20:30.
    PubMed     Abstract available

  213. SUN SW, Chen L, Zhou M, Wu JH, et al
    BAMBI regulates macrophages inducing the differentiation of Treg through the TGF-beta pathway in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:26.
    PubMed     Abstract available

    January 2019
  214. ZHOU T, Huang X, Ma J, Zhou Y, et al
    Association of plasma soluble CD14 level with asthma severity in adults: a case control study in China.
    Respir Res. 2019;20:19.
    PubMed     Abstract available

  215. LU Y, Chang R, Yao J, Xu X, et al
    Effectiveness of long-term using statins in COPD - a network meta-analysis.
    Respir Res. 2019;20:17.
    PubMed     Abstract available

  216. SRIDHAR S, Liu H, Pham TH, Damera G, et al
    Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases.
    Respir Res. 2019;20:14.
    PubMed     Abstract available

  217. KUBO F, Ariestanti DM, Oki S, Fukuzawa T, et al
    Loss of the adhesion G-protein coupled receptor ADGRF5 in mice induces airway inflammation and the expression of CCL2 in lung endothelial cells.
    Respir Res. 2019;20:11.
    PubMed     Abstract available

  218. WEDZICHA JA, Singh D, Tsiligianni I, Jenkins C, et al
    Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study.
    Respir Res. 2019;20:4.
    PubMed     Abstract available

  219. FANER R, Morrow JD, Casas-Recasens S, Cloonan SM, et al
    Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis.
    Respir Res. 2019;20:5.
    PubMed     Abstract available

  220. ERRIAH M, Pabreja K, Fricker M, Baines KJ, et al
    Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma.
    Respir Res. 2019;20:1.
    PubMed     Abstract available

  221. MORICHIKA D, Miyahara N, Fujii U, Taniguchi A, et al
    A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation.
    Respir Res. 2019;20:2.
    PubMed     Abstract available

    December 2018
  222. CRISAFULLI E, Ielpo A, Barbeta E, Ceccato A, et al
    Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study.
    Respir Res. 2018;19:261.
    PubMed     Abstract available

  223. BHATT SP, Nath HP, Kim YI, Ramachandran R, et al
    Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.
    Respir Res. 2018;19:257.
    PubMed     Abstract available

  224. GAFAR F, Boudewijn IM, Cox CA, Vonk JM, et al
    Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Res. 2018;19:256.
    PubMed     Abstract available

  225. WATZ H, Tetzlaff K, Magnussen H, Mueller A, et al
    Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
    Respir Res. 2018;19:251.
    PubMed     Abstract available

  226. LENOIR A, Fitting JW, Marques-Vidal PM, Vollenweider P, et al
    GLI 2012 equations define few spirometric anomalies in the general population: the PneumoLaus study.
    Respir Res. 2018;19:250.
    PubMed     Abstract available

  227. NEVILLE MDC, Choi J, Lieberman J, Duan QL, et al
    Identification of deleterious and regulatory genomic variations in known asthma loci.
    Respir Res. 2018;19:248.
    PubMed     Abstract available

  228. FLYNN RWV, MacDonald TM, Chalmers JD, Schembri S, et al
    The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.
    Respir Res. 2018;19:249.
    PubMed     Abstract available

  229. ERIKSSON STROM J, Pourazar J, Linder R, Blomberg A, et al
    Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking.
    Respir Res. 2018;19:244.
    PubMed     Abstract available

  230. PEREZ-BAUTISTA O, Montano M, Perez-Padilla R, Zuniga-Ramos J, et al
    Women with COPD by biomass show different serum profile of adipokines, incretins, and peptide hormones than smokers.
    Respir Res. 2018;19:239.
    PubMed     Abstract available

  231. GREGORIANO C, Dieterle T, Breitenstein AL, Durr S, et al
    Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial.
    Respir Res. 2018;19:237.
    PubMed     Abstract available

    November 2018
  232. ROSCIOLI E, Hamon R, Lester SE, Jersmann HPA, et al
    Airway epithelial cells exposed to wildfire smoke extract exhibit dysregulated autophagy and barrier dysfunction consistent with COPD.
    Respir Res. 2018;19:234.
    PubMed     Abstract available

  233. LI F, Xu M, Wang M, Wang L, et al
    Roles of mitochondrial ROS and NLRP3 inflammasome in multiple ozone-induced lung inflammation and emphysema.
    Respir Res. 2018;19:230.
    PubMed     Abstract available

  234. LEWIS TC, Metitiri EE, Mentz GB, Ren X, et al
    Influence of viral infection on the relationships between airway cytokines and lung function in asthmatic children.
    Respir Res. 2018;19:228.
    PubMed     Abstract available

  235. MILARA J, Diaz-Platas L, Contreras S, Ribera P, et al
    MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease.
    Respir Res. 2018;19:226.
    PubMed     Abstract available

  236. DRIESSEN MT, Whalen J, Seewoodharry Buguth B, Vallejo-Aparicio LA, et al
    Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
    Respir Res. 2018;19:224.
    PubMed     Abstract available

  237. XU W, Li R, Guan L, Wang K, et al
    Combination of inspiratory and expiratory muscle training in same respiratory cycle versus different cycles in COPD patients: a randomized trial.
    Respir Res. 2018;19:225.
    PubMed     Abstract available

  238. PIROZZI CS, Gu T, Quibrera PM, Carretta EE, et al
    Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
    Respir Res. 2018;19:223.
    PubMed     Abstract available

  239. NAYA IP, Tombs L, Muellerova H, Compton C, et al
    Long-term outcomes following first short-term clinically important deterioration in COPD.
    Respir Res. 2018;19:222.
    PubMed     Abstract available

  240. YANG J, Luo J, Yang L, Yang D, et al
    Efficacy and safety of antagonists for chemoattractant receptor-homologous molecule expressed on Th2 cells in adult patients with asthma: a meta-analysis and systematic review.
    Respir Res. 2018;19:217.
    PubMed     Abstract available

  241. RUTTING S, Papanicolaou M, Xenaki D, Wood LG, et al
    Dietary omega-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD.
    Respir Res. 2018;19:211.
    PubMed     Abstract available

    October 2018
  242. HAYDEN LP, Cho MH, Raby BA, Beaty TH, et al
    Childhood asthma is associated with COPD and known asthma variants in COPDGene: a genome-wide association study.
    Respir Res. 2018;19:209.
    PubMed     Abstract available

  243. LO D, Kennedy JL, Kurten RC, Panettieri RA Jr, et al
    Modulation of airway hyperresponsiveness by rhinovirus exposure.
    Respir Res. 2018;19:208.
    PubMed     Abstract available

  244. TASHKIN DP, Miravitlles M, Celli BR, Metzdorf N, et al
    Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT(R) trial.
    Respir Res. 2018;19:196.
    PubMed     Abstract available

    September 2018
  245. DOMINGO C, Palomares O, Sandham DA, Erpenbeck VJ, et al
    The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation.
    Respir Res. 2018;19:189.
    PubMed     Abstract available

  246. PARK HJ, Byun MK, Rhee CK, Kim K, et al
    Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study.
    Respir Res. 2018;19:185.
    PubMed     Abstract available

  247. KIRENGA BJ, Mugenyi L, de Jong C, Lucian Davis J, et al
    The impact of HIV on the prevalence of asthma in Uganda: a general population survey.
    Respir Res. 2018;19:184.
    PubMed     Abstract available

  248. STRODA A, Brandenburg V, Daher A, Cornelissen C, et al
    Serum phosphate and phosphate-regulatory hormones in COPD patients.
    Respir Res. 2018;19:183.
    PubMed     Abstract available

  249. CRISFORD H, Sapey E, Stockley RA
    Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases.
    Respir Res. 2018;19:180.
    PubMed     Abstract available

  250. ZIYAB AH, Mukherjee N, Kurukulaaratchy RJ, Zhang H, et al
    Leptin receptor gene polymorphisms and sex modify the association between acetaminophen use and asthma among young adults: results from two observational studies.
    Respir Res. 2018;19:179.
    PubMed     Abstract available

  251. HAGHIGHI B, Choi S, Choi J, Hoffman EA, et al
    Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).
    Respir Res. 2018;19:178.
    PubMed     Abstract available

  252. TONGA KO, King GG, Farah CS, Thamrin C, et al
    Steroid insensitive fixed airflow obstruction is not related to airway inflammation in older non-smokers with asthma.
    Respir Res. 2018;19:176.
    PubMed     Abstract available

  253. BARRECHEGUREN M, Gonzalez C, Miravitlles M
    What have we learned from observational studies and clinical trials of mild to moderate COPD?
    Respir Res. 2018;19:177.
    PubMed     Abstract available

  254. WINKLER A, Kahnert K, Behr J, Neurohr C, et al
    Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation.
    Respir Res. 2018;19:171.
    PubMed     Abstract available

  255. JANSON C, Johansson G, Stallberg B, Lisspers K, et al
    Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study.
    Respir Res. 2018;19:172.
    PubMed     Abstract available

  256. WATANABE M, Nakamoto K, Inui T, Sada M, et al
    Serum sST2 levels predict severe exacerbation of asthma.
    Respir Res. 2018;19:169.
    PubMed     Abstract available

  257. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR).
    Respir Res. 2018;19:168.
    PubMed     Abstract available

    August 2018
  258. MUELLER S, Gottschalk F, Groth A, Meeraus W, et al
    Primary data, claims data, and linked data in observational research: the case of COPD in Germany.
    Respir Res. 2018;19:161.
    PubMed     Abstract available

  259. MATUCCI A, Vultaggio A, Danesi R
    The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review.
    Respir Res. 2018;19:154.
    PubMed     Abstract available

  260. BURBANK AJ, Todoric K, Steele P, Rosen J, et al
    Age and African-American race impact the validity and reliability of the asthma control test in persistent asthmatics.
    Respir Res. 2018;19:152.
    PubMed     Abstract available

  261. GREULICH T, Rodriguez-Frias F, Belmonte I, Klemmer A, et al
    Real world evaluation of a novel lateral flow assay (AlphaKit(R) QuickScreen) for the detection of alpha-1-antitrypsin deficiency.
    Respir Res. 2018;19:151.
    PubMed     Abstract available

  262. ATANASOVA KR, Reznikov LR
    Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.
    Respir Res. 2018;19:149.
    PubMed     Abstract available

  263. JOHNSON KM, Tan WC, Bourbeau J, Sin DD, et al
    The diagnostic performance of patient symptoms in screening for COPD.
    Respir Res. 2018;19:147.
    PubMed     Abstract available

  264. REEVES SR, Kang I, Chan CK, Barrow KA, et al
    Asthmatic bronchial epithelial cells promote the establishment of a Hyaluronan-enriched, leukocyte-adhesive extracellular matrix by lung fibroblasts.
    Respir Res. 2018;19:146.
    PubMed     Abstract available

  265. MOHEIMANI F, Koops J, Williams T, Reid AT, et al
    Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics.
    Respir Res. 2018;19:145.
    PubMed     Abstract available

    July 2018
  266. WILLIAMS NP, Ostridge K, Devaster JM, Kim V, et al
    Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD.
    Respir Res. 2018;19:143.
    PubMed     Abstract available

  267. XU S, Tsai A, Sze MA, Vucic EA, et al
    Decreased microbiome diversity in the HIV small airway epithelium.
    Respir Res. 2018;19:140.
    PubMed     Abstract available

  268. STOCKLEY RA, Edgar RG, Starkey S, Turner AM, et al
    Health status decline in alpha-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?
    Respir Res. 2018;19:137.
    PubMed     Abstract available

  269. BARDSLEY G, Daley-Yates P, Baines A, Kempsford R, et al
    Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.
    Respir Res. 2018;19:133.
    PubMed     Abstract available

  270. SHIN SH, Park HY, Kang D, Cho J, et al
    Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease.
    Respir Res. 2018;19:134.
    PubMed     Abstract available

    June 2018
  271. PHILPOTT CM, Erskine S, Hopkins C, Kumar N, et al
    Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.
    Respir Res. 2018;19:129.
    PubMed     Abstract available

  272. BURGEL PR, Laurendeau C, Raherison C, Fuhrman C, et al
    An attempt at modeling COPD epidemiological trends in France.
    Respir Res. 2018;19:130.
    PubMed     Abstract available

  273. KHO AT, McGeachie MJ, Moore KG, Sylvia JM, et al
    Circulating microRNAs and prediction of asthma exacerbation in childhood asthma.
    Respir Res. 2018;19:128.
    PubMed     Abstract available

  274. XIN T, Chen M, Duan L, Xu Y, et al
    Interleukin-32: its role in asthma and potential as a therapeutic agent.
    Respir Res. 2018;19:124.
    PubMed     Abstract available

  275. ANZUETO AR, Kostikas K, Mezzi K, Shen S, et al
    Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study.
    Respir Res. 2018;19:121.
    PubMed     Abstract available

  276. ESTIRADO C, Ceccato A, Guerrero M, Huerta A, et al
    Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.
    Respir Res. 2018;19:119.
    PubMed     Abstract available

  277. TOLEDO-PONS N, Noell G, Jahn A, Iglesias A, et al
    Bone marrow characterization in COPD: a multi-level network analysis.
    Respir Res. 2018;19:118.
    PubMed     Abstract available

  278. XU S, Vucic EA, Shaipanich T, Lam S, et al
    Decreased telomere length in the small airway epithelium suggests accelerated aging in the lungs of persons living with human immunodeficiency virus (HIV).
    Respir Res. 2018;19:117.
    PubMed     Abstract available

  279. MATUCCI A, Vultaggio A, Maggi E, Kasujee I, et al
    Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
    Respir Res. 2018;19:113.
    PubMed     Abstract available

  280. CARPAIJ OA, Muntinghe FOW, Wagenaar MB, Habing JW, et al
    Serum periostin does not reflect type 2-driven inflammation in COPD.
    Respir Res. 2018;19:112.
    PubMed     Abstract available

  281. VISHWESWARAIAH S, George L, Purushothaman N, Ganguly K, et al
    A candidate gene identification strategy utilizing mouse to human big-data mining: "3R-tenet" in COPD genetic research.
    Respir Res. 2018;19:92.
    PubMed     Abstract available

  282. KAHNERT K, Alter P, Welte T, Huber RM, et al
    Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach.
    Respir Res. 2018;19:110.
    PubMed     Abstract available

  283. SUN J, Gu X, Wu N, Zhang P, et al
    Human antigen R enhances the epithelial-mesenchymal transition via regulation of ZEB-1 in the human airway epithelium.
    Respir Res. 2018;19:109.
    PubMed     Abstract available

  284. TWOREK D, Majewski S, Szewczyk K, Kiszalkiewicz J, et al
    The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
    Respir Res. 2018;19:108.
    PubMed     Abstract available

    May 2018
  285. JAAT FG, Hasan SF, Perry A, Cookson S, et al
    Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease.
    Respir Res. 2018;19:106.
    PubMed     Abstract available

  286. ALIAGAS E, Munoz-Esquerre M, Cuevas E, Careta O, et al
    Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.
    Respir Res. 2018;19:103.
    PubMed     Abstract available

  287. FISK M, Cheriyan J, Mohan D, McEniery CM, et al
    Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease.
    Respir Res. 2018;19:100.
    PubMed     Abstract available

  288. CLOOTS RHE, Poynter ME, Terwindt E, Lamers WH, et al
    Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma.
    Respir Res. 2018;19:98.
    PubMed     Abstract available

  289. GODTFREDSEN NS, Jorgensen DV, Marsaa K, Ulrik CS, et al
    Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.
    Respir Res. 2018;19:97.
    PubMed     Abstract available

  290. BELVISI MG, Baker K, Malloy N, Raemdonck K, et al
    Modelling the asthma phenotype: impact of cigarette smoke exposure.
    Respir Res. 2018;19:89.
    PubMed     Abstract available

  291. GAO YH, Cui JJ, Wang LY, Yin KQ, et al
    Arterial stiffness in adults with steady-state bronchiectasis: association with clinical indices and disease severity.
    Respir Res. 2018;19:86.
    PubMed     Abstract available

  292. BULSEI J, Leroy S, Perotin JM, Mal H, et al
    Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study).
    Respir Res. 2018;19:84.
    PubMed     Abstract available

  293. PERRY MM, Tildy B, Papi A, Casolari P, et al
    The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide.
    Respir Res. 2018;19:85.
    PubMed     Abstract available

    April 2018
  294. BLOECHLIGER M, Reinau D, Spoendlin J, Chang SC, et al
    Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.
    Respir Res. 2018;19:75.
    PubMed     Abstract available

  295. SCHWARZKOPF L, Witt S, Waelscher J, Polke M, et al
    Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis.
    Respir Res. 2018;19:73.
    PubMed     Abstract available

  296. BERG T, Hegelund-Myrback T, Ockinger J, Zhou XH, et al
    Expression of MATE1, P-gp, OCTN1 and OCTN2, in epithelial and immune cells in the lung of COPD and healthy individuals.
    Respir Res. 2018;19:68.
    PubMed     Abstract available

  297. LINDER R, Ronmark E, Pourazar J, Behndig AF, et al
    Proteolytic biomarkers are related to prognosis in COPD- report from a population-based cohort.
    Respir Res. 2018;19:64.
    PubMed     Abstract available

  298. CHALMERS JD, Poole C, Webster S, Tebboth A, et al
    Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research
    Respir Res. 2018;19:63.
    PubMed     Abstract available

  299. DIAZ AA, Martinez CH, Harmouche R, Young TP, et al
    Pectoralis muscle area and mortality in smokers without airflow obstruction.
    Respir Res. 2018;19:62.
    PubMed     Abstract available

  300. OBEIDAT M, Zhou G, Li X, Hansel NN, et al
    The genetics of smoking in individuals with chronic obstructive pulmonary disease.
    Respir Res. 2018;19:59.
    PubMed     Abstract available

  301. GREULICH T, Hohlfeld JM, Neuser P, Lueer K, et al
    A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.
    Respir Res. 2018;19:55.
    PubMed     Abstract available

    March 2018
  302. WANG J, Lv H, Luo Z, Mou S, et al
    Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
    Respir Res. 2018;19:47.
    PubMed     Abstract available

  303. VAN BUUL AR, Kasteleyn MJ, Chavannes NH, Taube C, et al
    Physical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptoms.
    Respir Res. 2018;19:49.
    PubMed     Abstract available

  304. SAKORNSAKOLPAT P, Morrow JD, Castaldi PJ, Hersh CP, et al
    Integrative genomics identifies new genes associated with severe COPD and emphysema.
    Respir Res. 2018;19:46.
    PubMed     Abstract available

  305. DE BROUWER B, Drent M, van den Ouweland JMW, Wijnen PA, et al
    Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis.
    Respir Res. 2018;19:45.
    PubMed     Abstract available

  306. PADILLA-GALO A, Olveira C, Fernandez de Rota-Garcia L, Marco-Galve I, et al
    Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients.
    Respir Res. 2018;19:43.
    PubMed     Abstract available

  307. YANG M, Kohler M, Heyder T, Forsslund H, et al
    Proteomic profiling of lung immune cells reveals dysregulation of phagocytotic pathways in female-dominated molecular COPD phenotype.
    Respir Res. 2018;19:39.
    PubMed     Abstract available

  308. YANG M, Kohler M, Heyder T, Forsslund H, et al
    Long-term smoking alters abundance of over half of the proteome in bronchoalveolar lavage cell in smokers with normal spirometry, with effects on molecular pathways associated with COPD.
    Respir Res. 2018;19:40.
    PubMed     Abstract available

  309. KERWIN EM, Spangenthal S, Kollar C, St Rose E, et al
    A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD.
    Respir Res. 2018;19:38.
    PubMed     Abstract available

  310. PARK HY, Lee SY, Kang D, Cho J, et al
    Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.
    Respir Res. 2018;19:36.
    PubMed     Abstract available

  311. CASTELLO LM, Bellan M
    Commenting on "Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from ACE 2 study" by Jacob A. Winther and colleagues.
    Respir Res. 2018;19:35.
    PubMed     Abstract available

    February 2018
  312. OSTRIDGE K, Williams NP, Kim V, Harden S, et al
    Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD.
    Respir Res. 2018;19:31.
    PubMed     Abstract available

  313. LEITAO FILHO FS, Ra SW, Mattman A, Schellenberg RS, et al
    Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.
    Respir Res. 2018;19:30.
    PubMed     Abstract available

  314. JOHNSON KM, Bryan S, Ghanbarian S, Sin DD, et al
    Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Respir Res. 2018;19:26.
    PubMed     Abstract available

    January 2018
  315. FAWZY A, Putcha N, Paulin LM, Aaron CP, et al
    Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.
    Respir Res. 2018;19:20.
    PubMed     Abstract available

  316. BREMNER PR, Birk R, Brealey N, Ismaila AS, et al
    Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.
    Respir Res. 2018;19:19.
    PubMed     Abstract available

  317. MAHMUTOVIC PERSSON I, Menzel M, Ramu S, Cerps S, et al
    IL-1beta mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation.
    Respir Res. 2018;19:16.
    PubMed     Abstract available

  318. DI MARCO F, Sotgiu G, Santus P, O'Donnell DE, et al
    Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis.
    Respir Res. 2018;19:18.
    PubMed     Abstract available

  319. LARSSON K, Stallberg B, Lisspers K, Telg G, et al
    Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR).
    Respir Res. 2018;19:12.
    PubMed     Abstract available

  320. OLLOQUEQUI J, Jaime S, Parra V, Cornejo-Cordova E, et al
    Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.
    Respir Res. 2018;19:13.
    PubMed     Abstract available

  321. MIRAVITLLES M, Roche N, Cardoso J, Halpin D, et al
    Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.
    Respir Res. 2018;19:11.
    PubMed     Abstract available

  322. USMANI OS, Lavorini F, Marshall J, Dunlop WCN, et al
    Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.
    Respir Res. 2018;19:10.
    PubMed     Abstract available

  323. MANORAK W, Idahosa C, Gupta K, Roy S, et al
    Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1.
    Respir Res. 2018;19:1.
    PubMed     Abstract available

    December 2017
  324. BAO A, Yang H, Ji J, Chen Y, et al
    Involvements of p38 MAPK and oxidative stress in the ozone-induced enhancement of AHR and pulmonary inflammation in an allergic asthma model.
    Respir Res. 2017;18:216.
    PubMed     Abstract available

  325. GRAMEGNA A, Amati F, Terranova L, Sotgiu G, et al
    Neutrophil elastase in bronchiectasis.
    Respir Res. 2017;18:211.
    PubMed     Abstract available

  326. VARGAS A, Boivin R, Cano P, Murcia Y, et al
    Neutrophil extracellular traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma.
    Respir Res. 2017;18:207.
    PubMed     Abstract available

  327. KASTELEYN MJ, Bonten TN, de Mutsert R, Thijs W, et al
    Pulmonary function, exhaled nitric oxide and symptoms in asthma patients with obesity: a cross-sectional study.
    Respir Res. 2017;18:205.
    PubMed     Abstract available

  328. WANG G, Zhang X, Zhang HP, Wang L, et al
    Corticosteroid plus beta2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.
    Respir Res. 2017;18:203.
    PubMed     Abstract available

    November 2017
  329. LO CY, Michaeloudes C, Bhavsar PK, Huang CD, et al
    Reduced suppressive effect of beta2-adrenoceptor agonist on fibrocyte function in severe asthma.
    Respir Res. 2017;18:194.
    PubMed     Abstract available

  330. ZHANG L, Zhang J, Gao P
    The potential of interleukin-37 as an effective therapeutic agent in asthma.
    Respir Res. 2017;18:192.
    PubMed     Abstract available

  331. DESCHILDRE A, Pichavant M, Engelmann I, Langlois C, et al
    Virus-triggered exacerbation in allergic asthmatic children: neutrophilic airway inflammation and alteration of virus sensors characterize a subgroup of patients.
    Respir Res. 2017;18:191.
    PubMed     Abstract available

  332. ROCHA NN, de Oliveira MV, Braga CL, Guimaraes G, et al
    Ghrelin therapy improves lung and cardiovascular function in experimental emphysema.
    Respir Res. 2017;18:185.
    PubMed     Abstract available

  333. PEREZ-DE-LLANO L, Cosio BG
    Asthma-COPD overlap is not a homogeneous disorder: further supporting data.
    Respir Res. 2017;18:183.
    PubMed     Abstract available

    September 2017
  334. MENENDEZ R, Mendez R, Polverino E, Rosales-Mayor E, et al
    Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study.
    Respir Res. 2017;18:176.
    PubMed     Abstract available

  335. TORAIH EA, Hussein MH, Al Ageeli E, Riad E, et al
    Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma.
    Respir Res. 2017;18:169.
    PubMed     Abstract available

    May 2017
  336. RAVI AK, Plumb J, Gaskell R, Mason S, et al
    COPD monocytes demonstrate impaired migratory ability.
    Respir Res. 2017;18:90.
    PubMed     Abstract available

  337. PUNEKAR YS, Sharma S, Pahwa A, Takyar J, et al
    Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis.
    Respir Res. 2017;18:86.
    PubMed     Abstract available

  338. KOLSUM U, Donaldson GC, Singh R, Barker BL, et al
    Blood and sputum eosinophils in COPD; relationship with bacterial load.
    Respir Res. 2017;18:88.
    PubMed     Abstract available

  339. DOMINGO E, Grignola JC, Aguilar R, Messeguer ML, et al
    Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.
    Respir Res. 2017;18:85.
    PubMed     Abstract available

  340. BODAS M, Vij N
    Augmenting autophagy for prognosis based intervention of COPD-pathophysiology.
    Respir Res. 2017;18:83.
    PubMed     Abstract available

  341. LAKHDAR R, Drost EM, MacNee W, Bastos R, et al
    2D-DIGE proteomic analysis of vastus lateralis from COPD patients with low and normal fat free mass index and healthy controls.
    Respir Res. 2017;18:81.
    PubMed     Abstract available

  342. MURRAY LA, Dunmore R, Camelo A, Da Silva CA, et al
    Acute cigarette smoke exposure activates apoptotic and inflammatory programs but a second stimulus is required to induce epithelial to mesenchymal transition in COPD epithelium.
    Respir Res. 2017;18:82.
    PubMed     Abstract available

  343. DUIVERMAN ML, Maagh P, Magnet FS, Schmoor C, et al
    Impact of High-Intensity-NIV on the heart in stable COPD: a randomised cross-over pilot study.
    Respir Res. 2017;18:76.
    PubMed     Abstract available

  344. WEIDNER J, Jarenback L, de Jong K, Vonk JM, et al
    Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.
    Respir Res. 2017;18:77.
    PubMed     Abstract available

    April 2017
  345. OBEIDAT M, Nie Y, Chen V, Shannon CP, et al
    Network-based analysis reveals novel gene signatures in peripheral blood of patients with chronic obstructive pulmonary disease.
    Respir Res. 2017;18:72.
    PubMed     Abstract available

  346. MIRAVITLLES M, Ribera A
    Understanding the impact of symptoms on the burden of COPD.
    Respir Res. 2017;18:67.
    PubMed     Abstract available

  347. MATSUI H, Jo T, Fushimi K, Yasunaga H, et al
    Outcomes after early and delayed rehabilitation for exacerbation of chronic obstructive pulmonary disease: a nationwide retrospective cohort study in Japan.
    Respir Res. 2017;18:68.
    PubMed     Abstract available

  348. KHALAF RM, Lea SR, Metcalfe HJ, Singh D, et al
    Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi.
    Respir Res. 2017;18:61.
    PubMed     Abstract available

  349. KARL FM, Holle R, Bals R, Greulich T, et al
    Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.
    Respir Res. 2017;18:60.
    PubMed     Abstract available

  350. CORDOBA-LANUS E, Cazorla-Rivero S, Espinoza-Jimenez A, de-Torres JP, et al
    Telomere shortening and accelerated aging in COPD: findings from the BODE cohort.
    Respir Res. 2017;18:59.
    PubMed     Abstract available

    March 2017
  351. LEVAN TD, Smith LM, Heires AJ, Mikuls TR, et al
    Interaction of CD14 haplotypes and soluble CD14 on pulmonary function in agricultural workers.
    Respir Res. 2017;18:49.
    PubMed     Abstract available

  352. ROOS AB, Mori M, Gura HK, Lorentz A, et al
    Increased IL-17RA and IL-17RC in End-Stage COPD and the Contribution to Mast Cell Secretion of FGF-2 and VEGF.
    Respir Res. 2017;18:48.
    PubMed     Abstract available

  353. NAMBA Y, Togo S, Tulafu M, Kadoya K, et al
    Combination of glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processes.
    Respir Res. 2017;18:46.
    PubMed     Abstract available

    February 2017
  354. MARTINEZ CH, Freeman CM, Nelson JD, Murray S, et al
    GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
    Respir Res. 2017;18:42.
    PubMed     Abstract available

  355. BAZZAN E, Turato G, Tine M, Radu CM, et al
    Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity.
    Respir Res. 2017;18:40.
    PubMed     Abstract available

  356. WESTERIK JA, Metting EI, van Boven JF, Tiersma W, et al
    Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD.
    Respir Res. 2017;18:31.
    PubMed     Abstract available

    January 2017
  357. ZARCONE MC, van Schadewijk A, Duistermaat E, Hiemstra PS, et al
    Diesel exhaust alters the response of cultured primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD) to non-typeable Haemophilus influenzae.
    Respir Res. 2017;18:27.
    PubMed     Abstract available

  358. CAZZOLA M, Calzetta L, Facciolo F, Rogliani P, et al
    Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
    Respir Res. 2017;18:26.
    PubMed     Abstract available

  359. BLASI F, Canonica GW, Miravitlles M
    Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?
    Respir Res. 2017;18:19.
    PubMed     Abstract available

  360. KAHNERT K, Lucke T, Biertz F, Lechner A, et al
    Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort.
    Respir Res. 2017;18:14.
    PubMed     Abstract available

  361. SALOMON J, Stolz D, Domenighetti G, Frey JG, et al
    Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study.
    Respir Res. 2017;18:13.
    PubMed     Abstract available

  362. TOPALOVIC M, Exadaktylos V, Troosters T, Celis G, et al
    Non-linear parameters of specific resistance loops to characterise obstructive airways diseases.
    Respir Res. 2017;18:9.
    PubMed     Abstract available

  363. REISNER C, Fabbri LM, Kerwin EM, Fogarty C, et al
    A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension Delivery Technology in patients with moderate-to-very severe chronic obstruct
    Respir Res. 2017;18:8.
    PubMed     Abstract available

  364. DANG X, Qu X, Wang W, Liao C, et al
    Bioinformatic analysis of microRNA and mRNA Regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease.
    Respir Res. 2017;18:4.
    PubMed     Abstract available

  365. BATTAGLIA S, Scichilone N
    Eligibility of real-life patients with COPD for inclusion in RCTs: a commentary.
    Respir Res. 2017;18:5.
    PubMed     Abstract available

  366. SHUKLA SD, Mahmood MQ, Weston S, Latham R, et al
    The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL).
    Respir Res. 2017;18:6.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.